The bill outlines the operations and funding mechanisms of the Vaccine Purchase Trust Fund in Massachusetts, which supports a universal purchase system for routine childhood immunizations. The fund is financed through assessments charged to health insurance carriers, with the Department of Public Health overseeing the procurement and distribution of vaccines. In Fiscal Year 2024 (FY24), the fund collected $208 million, resulting in a surplus of $44.7 million to be carried into FY25. The report highlights the importance of maintaining high vaccination rates among children in the Commonwealth, with nearly 80% of children born in 2019 and 2020 completing the full seven-vaccine series by their second birthday.

The bill also details the establishment of a vaccine program advisory council, which will recommend vaccine types and funding needs based on routine immunization schedules. Additionally, it mandates that each surcharge payor must provide benefits for routine childhood immunizations without any cost-sharing provisions. The FY24 assessment percentage was set at 6.71%, exceeding the health care cost growth benchmark due to the addition of new vaccines, including those for COVID-19 and respiratory syncytial virus (RSV). The bill emphasizes the critical role of the Vaccine Purchase Trust Fund in ensuring access to vaccines and maintaining Massachusetts' status as a leader in childhood vaccination rates.